# UNIVERSITY OF MICHIGAN AT ANN ARBOR: Targeting the ER-resident AMPylase FICD to Ameliorate Spinocerebellar Ataxia Type 3

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF MICHIGAN AT ANN ARBOR |
| Location | ANN ARBOR, MI |
| Project | Targeting the ER-resident AMPylase FICD to Ameliorate Spinocerebellar Ataxia Type 3 |
| Project number | 1R21NS151155-01 |
| Mechanism | R21 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $418,440 |
| Awarded | 2026-09-10 |
| Project period | 2026-09-11 to 2028-08-31 |
| UEI | GNJ7BBP73WE9 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11437540). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.